ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$8.63
-7.16%
Mkt Cap $8.85B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (6 analysts)
$13.00
Range $12.00 – $15.00
Implied Upside
+50.7%
Consensus $13.00 vs current $8.63
NASDAQ·Healthcare·Biotechnology
$8.63
-7.16%
Mkt Cap $8.85B
Buy
6
Hold
0
Sell
0
Price Target (6 analysts)
$13.00
Range $12.00 – $15.00
+50.7%
Consensus $13.00 vs current $8.63